FinaBio Signs Development Agreement with Kunming

Fina Biosolutions LLC of Rockville, MD has signed a development agreement for two conjugate vaccines with the Chinese Institute of Medical Biology (Kunming), part of the Chinese Academy of Medicine. The Kunming Institute is one of China’s premier virology institute. FinaBio will provide laboratory and consulting services to assist them in developing conjugate vaccines for bacterial meningitis. FinaBio will develop production protocols, train scientists and assist in manufacturing scale-up. The agreement follows a lecture visit to the Kunming Institute by Andrew Lees, Fina Biosolutions’ scientific director.